Beijing Collaborative Innovation Centre for Cardiovascular Disorders;
the Key Laboratory of Remodeling-Related Cardiovascular Disease;
Ministry of Education;
Beijing Anzhen Hospital;
Capital Medical University;
Beijing 100029;
China;
Beijing Institute of Heart;
Lung and Blood Vessel Diseases;
Beijing 100029;
China;
Department of Cardiology;
Beijing Anzhen Hospital;
Capital Medical University;
Beijing 100029;
China;
aldosterone; concentric remodeling; prognosis; HFpEF; liquid chromatography-tandem mass spectrometry;